NCT07117344Completed
Biomarkers in Ankylosing Spondylitis
"Progranulin in Ankylosing Spondylitis Patients: A Potential Biomarker?"
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
In this study, we aimed to compare serum PGRN(progranulin) and TNF-α levels in AS patients with healthy controls and to determine the relationship between TNF-α inhibitor use and PGRN levels in AS patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 160 (actual)
- First submitted
- 5 Aug 2025
- Start date
- 15 Jan 2026
- Primary completion date
- 20 May 2026
- Lead sponsor
- Kirsehir Ahi Evran Universitesi
- Diseases
- Ankylosing spondylitis
- NCT number
- NCT07117344
What you commit to
- Study type: Observational
- Participants enrolled: 160
- From 15 Jan 2026 to the primary completion date, 20 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having concurrent secondary rheumatic disease other than Axial Spondyloarthropathy
Other illness
- Having signs of acute or chronic infection
- Presence of malignancy
Other
- Pregnancy or lactation
Who the study is looking for
- Between the ages of 20-65
- Signing the informed consent form
- Axial spondyloarthropathy diagnosis according to ASAS 2009 criteria
Age in the registry: 20 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kırşehir Ahi Evran University Coordinator of this site? Confirm its status | Kırşehir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.